Galapagos, NovAliX join forces for integrated drug discovery
Belgian biotechnology company Galapagos has signed an integrated drug discovery partnership with contract research organisation (CRO) NovAliX. As per the agreement, NovAliX will acquire Galapagos’ drug discovery and